MPI Research has partnered up with two imaging outfits to open a state-of-the-art center for drug developers, and the trio has broken ground on what it calls a first-of-its-kind facility.
Along with InviCRO and 3D Imaging, MPI is pooling its imaging resources into a one-stop shop, developing a facility that pairs cyclotron imaging capabilities with an on-site vivarium, allowing researchers to conduct drug radiolabeling and in-depth studies on a variety of animal models.
The 10,000-square-foot imaging center will sit alongside MPI's headquarters in Mattawan, MI, and the company expects to bring the facility online by spring 2014.
Once operational, the center will draw on the prowesses of each partner, the companies said, pulling in MPI's global client base, InviCRO's molecular imaging informatics team and 3D Imaging's radiopharmaceutical group.
"Only the Imaging Center at MPI Research will offer translational imaging capabilities all under one roof," InviCRO co-founder Jack Hoppin said in a statement. "This will fill a void that is not being addressed anywhere in the world and, most importantly, will speed drug discovery and development programs to market."
- read the announcement